11/03/2022
Key Takeaways from the 2022 Industrial H**p Summit:
- Challenges and risks remain, but the future is still bright for h**p, and the industry is well-positioned for continued growth on all fronts. As legal and regulatory foundations continue to settle and develop, it is imperative that h**p participants of all kinds – cannabinoid, industrial, or other focused uses – stay abreast of these changes and developments.
- William "Bill" Richmond, Chief of the U.S. Domestic H**p Production Program It is clear that he and his staff are committed to the continued growth and development of a viable domestic U.S. h**p production market.
- Cannabinoid and floral production continues to lead the way within the industry today. But, this sector of the industry continues to face regulatory uncertainty and most panelists agreed, the FDA is unlikely to create a regulatory pathway to market for h**p-derived cannabinoids in dietary supplements and/or food and beverage products.
- Fiber and food applications are making significant strides toward developing the necessary local and regional supply chains. There seems to be nationwide traction away from floral h**p production and a corresponding rise in fiber and grain processing plants and facilities.
